Blocked chest tubes can lead to Retained Blood Syndrome (RBS) – the composite of drainage-related post-cardiothoracic surgery complications that are detrimental to patient outcomes and may require early or late reinterventions.
Retained Blood Syndrome (RBS) complications can occur at any stage of recovery and may include hemothorax, pericardial tamponade, bloody pleural or pericardial effusion, postoperative atrial fibrillation (POAF), acute kidney injury and stroke.
All Patients are at Risk
President Clinton readmitted nine months post CABG surgery
“A collection of bloody fluid caused scar tissue to form and squeeze the lower lobe of his left lung, impeding his breathing capacity by more than 25%…
…doctors removed a large, unspecified amount of bloody fluid… (then found) a large thick rind of inflammatory tissue encasing the lower lobe of the lung…some sections were five to eight millimeters (thick).”
source: March 11, 2005
The incidence of complications associated with Retained Blood Syndrome (RBS) is well documented. Two recently completed retrospective analyses demonstrated Retained Blood Syndrome (RBS) reintervention rates of 17%, based on ICD-9 codes incurred after the original procedure.
But that’s not the whole story. Individual hospital reintervention rates range from 16% for conventional cardiac surgery up to 51% for high risk invasive procedures. It’s now clear, all institutions are affected by the prevalence of Retained Blood Syndrome (RBS) and every hospital is somewhere on the bell curve.
Healthcare costs are seriously impacted by Retained Blood Syndrome (RBS). The average incremental cost of RBS per patient in the US is $28,814. In addition, RBS patients experience significantly longer length of stay and double the mortality rate.15
PleuraFlow® Active Clearance Technology® (ACT) may enable you to reduce the heavy economic and clinical burden of Retained Blood Syndrome (RBS). Start by understanding the impact of RBS. Calculate your hospital’s costs today.